A Phase II Multicenter, Open-Label, Single-Arm Dose Escalation Study of Asciminib Monotherapy in 2nd and 1st Line Chronic Phase - Chronic Myelogenous Leukemia (ASC2ESCALATE)

Protocol No
NOVARTIS-CABL001AUS08
Phase
II
Summary

This project is being done to see how safe and how well the study drug asciminib works
for participants with CML-CP who have had one prior therapy

Description
This project is being done to see how safe and how well the study drug asciminib works
for participants with CML-CP who have had one prior therapy
Participating Institutions
Froedtert Hospital
Moorland Reserve Health Center
Status
OPEN TO ACCRUAL